Sofie
Clinical trials sponsored by Sofie, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New scan aims to spot hidden cancer spread in stomach and esophageal tumors Results expected Aug 2027 (estimated)
-
New imaging agent could sharpen pancreatic cancer detection
Diagnosis CompletedThis study tested a radioactive tracer called [68Ga]FAPI-46, used with a PET scan, to see if it can better detect pancreatic cancer cells. 63 adults with early-stage pancreatic cancer received the tracer before surgery. The goal was to see how well the scan matches the actual can…
Phase 2 • Sponsor: SOFIE • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New PET tracer could sharpen cancer detection
Diagnosis CompletedThis study tested a new radioactive tracer called [18F]FAPI-74 for PET scans in people with gastrointestinal cancers, including liver, bile duct, stomach, pancreatic, and colorectal cancers. The goal was to see if the tracer can accurately detect cancer cells by comparing scan re…
Phase 2 • Sponsor: SOFIE • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC